Handelsavisen
prelaunch
Companies Financials GENA.NS
GE
GENA.NS NSE (India) Reinsurance

General Insurance Corporation of India

$387,45
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
2,54 %
Op margin
ROE
6,2 %
Net margin
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

General Insurance Corporation of India provides insurance and reinsurance services, primarily generating revenue through premium income and investment returns.

Business. General Insurance Corporation of India (GENA.NS) is an Indian insurance company headquartered in India that operates within the reinsurance industry. The firm generates revenue through a premium-income model, focusing on insurance activities. It is primarily listed on the National Stock Exchange of India (NSE). Specific details regarding operating segments and geographic revenue mix are not available.

Classification92 %
SectorFinancials
Business sectorInsurance
IndustryReinsurance
ActivityInsurance
Generated · model-assisted
Sell-side consensus
BUY5 analysts
4 buy0 hold1 sell
Avg 12m price target473,50

Analyst recommendations

5 analysts · consensus Buy
Buy4
Hold0
Sell1
12-month price target
473,50
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
5 analysts · indicative
Ownership
not yet wired
Profitability
6,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning GENA.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to GENA.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    General Insurance Corporation of India (GENA.NS) is an Indian insurance company headquartered in India that operates within the reinsurance industry. The firm generates revenue through a premium-income model, focusing on insurance activities. It is primarily listed on the National Stock Exchange of India (NSE). Specific details regarding operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorFinancials
    Business sectorInsurance
    IndustryReinsurance
    ActivityInsurance
    AI synthesis
    GENERATED

    General Insurance Corporation of India maintains a strong liquidity position, with cash and equivalents amounting to INR 248.55 billion, representing 64.0% of total equity. The company has no long-term debt, resulting in a debt-to-equity ratio of 0.0, which is significantly lower than the industry median. This capital structure provides a buffer against market volatility and supports operational flexibility.

    Profitability metrics indicate a return on equity (ROE) of 6.15% and a return on assets (ROA) of 1.4%. While ROE is in line with the industry median, ROA is below the median for reinsurance firms, suggesting that asset utilization could be optimized. Net income of INR 25.80 billion reflects a healthy operating margin, but the company's operating cash flow of -INR 2.12 billion indicates a reliance on non-operational cash flows to maintain liquidity.

    The company's revenue is concentrated in its core insurance and reinsurance segments, with no disclosed geographic diversification in the latest financials. This lack of geographic segmentation data limits the ability to assess exposure to regional economic shifts or regulatory changes.

    Looking ahead, the company is projected to maintain stable revenue growth, with no significant changes in operating income or net income expected in the next fiscal year. However, the absence of capital expenditure and the low dilution risk suggest a conservative growth strategy focused on maintaining existing operations rather than expansion.

    Risk factors include low liquidity and the potential for regulatory changes in the Indian insurance sector. The company has no immediate filing-based liquidity or dilution flags, and the risk assessment indicates a low probability of dilution in the near term. The absence of long-term debt reduces credit risk, but the negative operating cash flow could become a concern if it persists.

    Recent filings and transcripts do not highlight any material events or strategic shifts. The company's focus remains on maintaining solvency and meeting regulatory capital requirements. Analysts have assigned a mean price target of INR 473.50, with a median of INR 472.50, and a mean recommendation of 2.40, indicating a generally positive outlook.

    Key takeaways
    • The company has a strong liquidity position with no long-term debt and a debt-to-equity ratio of 0.0.
    • Return on equity is in line with industry medians, but return on assets is below the median, indicating potential inefficiencies in asset utilization.
    • Revenue is concentrated in core insurance and reinsurance segments, with no disclosed geographic diversification.
    • Analysts project a stable outlook with a mean price target of INR 473.50 and a mean recommendation of 2.40.
    • The company faces low liquidity and regulatory risks, with no immediate dilution concerns.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2025-05-26
    FY 2025 · Full-year highlights

    Operating income +14,5% YoY; Net income +11,2% YoY.

    Revenue
    Operating incomeINR 91.05B+14,5 % YoY
    Net incomeINR 74.32B+11,2 % YoY
    Free cash flowINR 69.63B+6,9 % YoY
    EPS
    Operating cash flowINR 19.76B+1 033,3 % YoY
    Financials
    Income statement
    Revenue
    Gross profit
    Operating incomeINR 91.05B
    Net incomeINR 74.32B
    Balance sheet
    Total assetsINR 1.95T
    Total liabilitiesINR 1.46T
    Total equityINR 486.59B
    Cash & equivalentsINR 10.37B
    Long-term debtINR 0.00
    Cash flow
    Operating cash flowINR 19.76B
    CapEx-INR 254.1M
    Free cash flowINR 69.63B
    SBC
    Highlights
    • Operating income +14,5% YoY
    • Net income +11,2% YoY
    • Free cash flow +6,9% YoY

    Valuation FY

    Market price
    $387,45
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $419.35B
    Net cash
    $248.55B
    Current ratio
    Debt / equity
    0.0
    ROA
    1.4%
    ROE
    6.2%
    Cash conversion
    -8.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    47,34
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    5
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-10 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate47,34
    Revenueno estimateno estimate411,3B INR
    Operating incomeno estimateno estimateno estimate
    Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution5 analysts
    Strong buy0
    Buy4
    Hold0
    Sell1
    Strong sell0
    12-month price target$473,50 · Median $472,50
    Low $339,00High $610,00
    EPS surprise
    −10,5 %
    reported vs consensus · miss
    Revenue surprise
    −10,7 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$339,00
    Mean$473,50
    Median$472,50
    High$610,00
    Spot$387,45
    +22.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    ROE6,2 %Below median
    D/E0,00Above median
    Cash Conv-0,08Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • General Insurance Corporation of India Market data — financials · 2026-05-28
    • General Insurance Corporation of India Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    GENA.NSCanonical
    NSE (India) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2025-05-26 20:30 UTCEARNINGSAnnual results — FY 2025 Net INR 74.32B
    2024-05-28 19:21 UTCEARNINGSAnnual results — FY 2024 Net INR 66.86B
    2023-05-25 16:51 UTCEARNINGSAnnual results — FY 2023 Net INR 69.07B
    2022-05-27 20:03 UTCEARNINGSAnnual results — FY 2022 Net INR 23.86B
    2021-06-29 20:52 UTCEARNINGSAnnual results — FY 2021 Net INR 19.92B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage